3 results
Primary: To compare the Major Molecular Response (MMR) rate at 24 weeks of ABL001 versus bosutinibSecondary: To compare additional parameters of the efficacy of ABL001 versus bosutinib. Safety, tolerability.
Primary:To compare the efficacy of asciminib versus Investigator selected TKI with respect to the proportion of patients that are in Major Molecular Response at Week 48. To compare the efficacy of asciminib versus Investigator selected TKI, within…
This pilot study assesses the performance of a robot-assisted microsurgery. Lympho-venular anastomosis(LVA) is the most difficult procedure in microsurgery at this moment. This LVA technique is applied to treat for example breast cancer related…